The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Anti‐Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?
Open accessAbstract
Summary: Anti‐Müllerian hormone (AMH) is a dimeric glycoprotein, a member of the transforming growth factor (TGF) superfamily. It is produced exclusively in the gonads and is involved in the regulation of follicular growth and development. In the ovary AMH is produced by the granulosa cells of early developing follicles and seems to be able to inhibit the initiation of primordial follicle growth and FSH‐induced follicle growth. As AMH is largely expressed throughout folliculogenesis, from the primary follicular stage towards the antral stage, serum levels of AMH may represent both the quantity and quality of the ovarian follicle pool. Compared to other ovarian tests, AMH seems to be the best marker reflecting the decline of reproductive age. AMH measurement could be useful in the prediction of the menopausal transition. It could also be used to predict poor ovarian response and possibly the prognosis of in vitro fertilization (IVF) cycles. AMH has been shown to be a good surrogate marker for polycystic ovary syndrome (PCOS). Finally, its use as a marker for granulosa cell tumours has been proposed. A clearer understanding of its role in ovarian physiology may help clinicians to find a role for AMH measurement in the field of reproductive medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weenen, C. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah015 · Cited by 1,285
Cate, R. L., Mattaliano, R. J., Hession, C., Tizard, R., Farber, N. M., Cheung, A., Ninfa, E. G., Frey, A. Z., Gash, D. J., Chow, E. P., et al. (1986) · Cell · doi:10.1016/0092-8674(86)90783-x · Cited by 1,022
Control of Primordial Follicle Recruitment by Anti-Müllerian Hormone in the Mouse Ovary1
Durlinger, A. L. L., Kramer, P., Karels, B., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., & Themmen, A. P. N. (1999) · Endocrinology · doi:10.1210/endo.140.12.7204 · Cited by 1,011
Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve
van Rooij, I. A. J. (2002) · Human Reproduction · doi:10.1093/humrep/17.12.3065 · Cited by 951
Antimüllerian hormone serum levels: a putative marker for ovarian aging
de Vet, A., Laven, J. S. E., de Jong, F. H., Themmen, A. P. N., & Fauser, B. C. J. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02993-4 · Cited by 887
Anti-Mullerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Ingraham, H. A., Nachtigal, M. W., Uilenbroek, J. T. J., Grootegoed, J. A., & Themmen, A. P. N. (2002) · Endocrinology · doi:10.1210/en.143.3.1076 · Cited by 843
Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Kumar, T. R., Matzuk, M. M., Rose, U. M., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., et al. (2001) · Endocrinology · doi:10.1210/en.142.11.4891 · Cited by 772
Müllerian-inhibiting substance function during mammalian sexual development
Behringer, R. R., Finegold, M. J., & Cate, R. L. (1994) · Cell · doi:10.1016/0092-8674(94)90251-8 · Cited by 679
Fanchin, R. (2003) · Human Reproduction · doi:10.1093/humrep/deg042 · Cited by 624
van Rooij, I. A. J., Broekmans, F. J. M., Scheffer, G. J., Looman, C. W. N., Habbema, J. D. F., de Jong, F. H., Fauser, B. J. C. M., Themmen, A. P. N., & te Velde, E. R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.029 · Cited by 582
Cited by
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp036 · Cited by 956
Self-citationSerum anti-Mullerian hormone throughout the human menstrual cycle
La Marca, A., Stabile, G., Artenisio, A. C., & Volpe, A. (2006) · Human Reproduction · doi:10.1093/humrep/del291 · Cited by 532
Self-citationBurger, H. G., Hale, G. E., Robertson, D. M., & Dennerstein, L. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm020 · Cited by 422
The antral follicle count: practical recommendations for better standardization
Broekmans, F. J. M., de Ziegler, D., Howles, C. M., Gougeon, A., Trew, G., & Olivennes, F. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.04.040 · Cited by 414
Ireland, J. L. H., Scheetz, D., Jimenez-Krassel, F., Themmen, A. P. N., Ward, F., Lonergan, P., Smith, G. W., Perez, G. I., Evans, A. C. O., & Ireland, J. J. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.108.071670 · Cited by 399
Anti-Mullerian hormone (AMH): what do we still need to know?
La Marca, A., Broekmans, F. J., Volpe, A., Fauser, B. C., Macklon, N. S., & on behalf of the ESHRE Special Interest Group for Reproductive Endocrinology - AMH Round Table (2009) · Human Reproduction · doi:10.1093/humrep/dep210 · Cited by 327
Self-citationLa Marca, A., Giulini, S., Tirelli, A., Bertucci, E., Marsella, T., Xella, S., & Volpe, A. (2007) · Human Reproduction · doi:10.1093/humrep/del421 · Cited by 327
Self-citationPiouka, A., Farmakiotis, D., Katsikis, I., Macut, D., Gerou, S., & Panidis, D. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90684.2008 · Cited by 316
Ireland, J. J., Smith, G. W., Scheetz, D., Jimenez-Krassel, F., Folger, J. K., Ireland, J. L. H., Mossa, F., Lonergan, P., & Evans, A. C. O. (2011) · Reproduction, Fertility and Development · doi:10.1071/rd10226 · Cited by 272
Birgit, B., Julius, H., Carsten, R., Maryam, S., Gabriel, F., Victoria, K., Margareta, F., & Outi, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0708 · Cited by 254
Effect of Hysterectomy With Ovarian Preservation on Ovarian Function
Moorman, P. G., Myers, E. R., Schildkraut, J. M., Iversen, E. S., Wang, F., & Warren, N. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318236fd12 · Cited by 254
Sexual size dimorphism in birds
Székely, T., Lislevand, T., & Figuerola, J. (2007) · Sex, Size and Gender Roles · doi:10.1093/acprof:oso/9780199208784.003.0004 · Cited by 160
Xu, N., Kwon, S., Abbott, D. H., Geller, D. H., Dumesic, D. A., Azziz, R., Guo, X., & Goodarzi, M. O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027286 · Cited by 155
“Given dysfunctional TGF-b signaling as a putative genetically-based mechanism for developing PCOS [24,25,26,27], our findings of altered methylation of TGFB3, TGFBR1, KRAS, BMP2, TFE3, Runx3 and Hoxc8, complement previous studies implicating TGF-b superfamily members or their regulators in the pathophysiology of PCOS,…”
BackgroundThe role of AMH in the pathophysiology of polycystic ovarian syndrome
Garg, D., & Tal, R. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.04.007 · Cited by 150
Hudecova, M., Holte, J., Olovsson, M., & Sundstrom Poromaa, I. (2009) · Human Reproduction · doi:10.1093/humrep/den482 · Cited by 127
Is polycystic ovary syndrome an exception for reproductive aging?
Ramezani Tehrani, F., Solaymani-Dodaran, M., Hedayati, M., & Azizi, F. (2010) · Human Reproduction · doi:10.1093/humrep/deq088 · Cited by 111
Age of menarche and time to pregnancy
Guldbrandsen, K., Hakonsen, L. B., Ernst, A., Toft, G., Lyngso, J., Olsen, J., & Ramlau-Hansen, C. H. (2014) · Human Reproduction · doi:10.1093/humrep/deu153 · Cited by 58
Falorni, A., Brozzetti, A., Aglietti, M. C., Esposito, R., Minarelli, V., Morelli, S., Sbroma Tomaro, E., & Marzotti, S. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04387.x · Cited by 25
Metadata
- Authors
- La Marca, A., & Volpe, A.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2006-05-05
- Volume
- 64
- Issue
- 6
- Pages
- 603-610
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2095294625
- Cited by
- 369
- References
- 61
- FWCI
- 18.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.